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LETTER TO THE EDITOR
Evaluation of Microvessel Density of Hepatocellular 
Carcinoma and Comparison with Benign Lesions of 
Liver: An Immunohistochemical Study 
 
 
Dear Editor, 
Hepatocellular carcinoma (HCC) is one of the most 
common malignancies in the world
1 that is frequently 
diagnosed by obtaining core needle biopsies. Howev-
er, distinguishing a well-differentiated HCC from be-
nign hepatic lesions, such as fatty liver, hepatitis, cir-
rhosis, and adenomas, particularly in these small 
specimens, can be quite challenging.
2,3 In this study, 
we used the microvessel density (MVD) index to help 
this differentiation. 
Samples were consisted of twenty HCCs and sev-
enteen benign hepatic lesions, diagnosed between 
1999 and 2009 in the Pathology Department of 
Ghaem and Imam-Reza hospitals, Mashhad, Iran. To 
evaluate the MVD, a polymer-based immunohisto-
chemical technique was performed for the detection of 
CD34, a highly sensitive angiogenesis marker.
4,5 Then, 
MVD was counted based on the Gasparini's criteria 
(The Chalkley point).
6 All statistical analyses were 
carried out using SPSS software. In order to compare 
means between groups, we used t test or its nonpara-
metric counterpart (Mann-Whitney U test). Receiver 
Operating Characteristic (ROC) curve analysis was 
done to assess the diagnostic accuracy of MVD.  
The male-to-female ratio was 7:3 for both malig-
nant and benign lesions and the groups were statisti-
cally matched for sex. The mean age was higher in 
patients with malignancy (60.7±15.8 vs. 44.3± 23.2 
years old, p=0.024). The only available case of ade-
nomatosis was associated with glycogen storage dis-
ease. The mean MVD was higher in HCC than benign 
lesions (129.1±44.1 vs. 74.0±39.6, p<0.0001). How-
ever, there was no statistically significant difference 
for mean MVD between benign and normal cases 
(47.8±8.1 vs. 74.0±37.4, p=0.200). Moreover, the 
mean MVD was not different between two sexes 
(141.2± 46.1 vs. 124.0±43.9, p=0.440).  
Different CD34 staining patterns were also exam-
ined. Complete immunostaining pattern was solely 
found in HCC and in the specimen with hepatic ade-
noma, while incomplete and negative staining patterns 
were seen in normal cases, cirrhosis, hepatitis and fatty 
liver. Immunostaining with sinusoidal pattern around 
nests and trabecules was found in six HCC cases.  
Table 1 shows the diagnostic indices of MVD us-
ing a cut-off point of 101 microvessels. In other 
words, MVD counts of more than 101 vessels are in 
favor of malignancy; whereas lower counts are seen 
in benign hepatic lesions.  
Several studies have evaluated the association be-
tween CD34 expression and HCC prognosis,
2,7 but 
only a limited number of investigations have been 
done to determine the diagnostic value of CD34 im-
munostaining method.
3 What is more, it has been 
questioned whether CD34 alone, regardless of its 
staining pattern, can be used to distinguish benign 
liver nodules from HCC. Based on a research done by 
Tanigava. et al., anti-CD34 staining was confined to 
vessels of the portal triad with weak staining in few 
sinusoids at the periportal area in benign lesions such 
as cirrhosis or chronic hepatitis cases (mean MVD± 
SD, 23±5 /0.74 mm
2). However, intensive and specif-
ic staining of sinusoid-like vessels was observed in all 
of the tumoral lesions using anti-CD34 antibody 
(mean MVD± SD, 297±88 /0.74 mm
2).
8 
Although MVD can be evaluated by several mark-
ers such as VEGF, CD105, vWF and CD34, some 
researchers have claimed that CD34 is the most sensi-
tive marker.
2,8 We also achieved good results with 
high sensitivity using this marker.  
Table 1: Diagnostic indices of microvessel density using CD34 immunostaining
Parameter  Value 95%  confidence  interval
Upper limit Lower limit
Sensitivity 0.85  0.94  0.63 
Specificity 0.82  0.93  0.58 
PPV 0.85  0.94  0.63 
NPV 0.82  0.93  0.58 
Area Under Curve  0.83  0.96  0.69 
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Overall, it seems that the MVD in HCC is higher 
compared to benign hepatic lesions except in cases of 
adenoma and FNH. Furthermore, the complete CD34 
staining pattern was virtually always found in HCC, 
and rarely in its benign mimickers. Conclusively, the 
results of this study show that the evaluation of 
MVD-CD34 in association with its immunostaining 
pattern, contributes to a reliable distinction between 
HCC and non-neoplastic liver diseases. 
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